Search research articles
Contact Us
Filters
Showing results (81-90 of 204) with videos related to
Page
of 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 31, 2015
Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
Tawanda Gumbo, Jotam G Pasipanodya, Klaus Romero, et al.
Journal of Global Antimicrobial Resistance
|
January 28, 2021
Potency of vancomycin against Mycobacterium tuberculosis in the hollow fiber system model
Shashikant Srivastava, Moti Chapagain, Johanna van Zyl, et al.
Antimicrobial Agents and Chemotherapy
|
January 29, 2015
Reply to "breakpoints and drug exposure are inevitably closely linked"
Tawanda Gumbo, Jotam G Pasipanodya, Peter Wash, et al.
The Journal of Infectious Diseases
|
March 10, 2010
Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol
Shashikant Srivastava, Sandirai Musuka, Carleton Sherman, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease
Devyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks
Shashikant Srivastava, Devyani Deshpande, Jotam Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy
|
March 6, 2013
Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths
Ronald G Hall, Mark A Swancutt, Claudia Meek, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease
Devyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
International Journal of Cardiology. Heart & Vasculature
|
April 10, 2019
Detectable prednisolone is delayed in pericardial fluid, compared with plasma of patients with tuberculous pericarditis: A pilot study
Justin Shenje, Tawanda Gumbo, Lubbe Wiesner, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Novel regimens for treatment of <i>Mycobacterium avium</i> lung disease based on advanced <i>in vitro</i> systems and the mathematics of basis functions
Shashikant Srivastava, Sanjay Singh, Gunavanthi D Boorgula, et al.
Page
of 21
Search research articles
Search
Showing results (81-90 of 204) with videos related to
Sort By:
Page
of 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 31, 2015
Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
Tawanda Gumbo, Jotam G Pasipanodya, Klaus Romero, et al.
Journal of Global Antimicrobial Resistance
|
January 28, 2021
Potency of vancomycin against Mycobacterium tuberculosis in the hollow fiber system model
Shashikant Srivastava, Moti Chapagain, Johanna van Zyl, et al.
Antimicrobial Agents and Chemotherapy
|
January 29, 2015
Reply to "breakpoints and drug exposure are inevitably closely linked"
Tawanda Gumbo, Jotam G Pasipanodya, Peter Wash, et al.
The Journal of Infectious Diseases
|
March 10, 2010
Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol
Shashikant Srivastava, Sandirai Musuka, Carleton Sherman, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease
Devyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 16, 2016
Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks
Shashikant Srivastava, Devyani Deshpande, Jotam Pasipanodya, et al.
Antimicrobial Agents and Chemotherapy
|
March 6, 2013
Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths
Ronald G Hall, Mark A Swancutt, Claudia Meek, et al.
The Journal of Antimicrobial Chemotherapy
|
September 20, 2017
Tedizolid is highly bactericidal in the treatment of pulmonary Mycobacterium avium complex disease
Devyani Deshpande, Shashikant Srivastava, Jotam G Pasipanodya, et al.
International Journal of Cardiology. Heart & Vasculature
|
April 10, 2019
Detectable prednisolone is delayed in pericardial fluid, compared with plasma of patients with tuberculous pericarditis: A pilot study
Justin Shenje, Tawanda Gumbo, Lubbe Wiesner, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Novel regimens for treatment of <i>Mycobacterium avium</i> lung disease based on advanced <i>in vitro</i> systems and the mathematics of basis functions
Shashikant Srivastava, Sanjay Singh, Gunavanthi D Boorgula, et al.
Page
of 21